CAR-TCR Summit

September 4, 2018

September 4-7 in Boston, Massachusetts

ICS is attending the 4th annual CAR-TCR Summit, the only dedicated, end-to-end summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies. The two main goals for this summit is to learn more about the discovery, translation and clinical development of CARTCR therapies, and ensure the accessibility, affordability and logistical delivery of current CAR-T cell therapies. Please reach out if you are attending and would like to set up time to talk.


ICS Team Members Attending CAR-TCR

Ann Pham Ann Pham
Business Development Manager
Keith Davidson Keith Davidson
Vice President, Finance
Matthew Letow Matthew Letow
Director, Business Development